New York, NY -- (SBWIRE) -- 01/21/2014 -- King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Today we bring special trend analysis of following stocks: Stemline Therapeutics Inc (NASDAQ:STML), NII Holdings Inc (NASDAQ:NIHD), Idenix Pharmaceuticals Inc (NASDAQ:IDIX), Pacific Biosciences of California (NASDAQ:PACB).
PLUS you’ll get KingPennyStock’s Pro Trading Rules Mini E-book absolutely FREE! Claim Your Copy
Stemline Therapeutics Inc (NASDAQ:STML) stock moved up 39.50% and finished the day at $30.44, while its opening price was $22.00. The company traded with the total volume of 1.40 million shares, while its average trading volume remained 187,860.00 shares. During the last one month it rose with the percentage of 55.94. Stemline Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing proprietary therapeutics that target cancer stem cells (CSCs) and tumor bulk.
For How Long STML will fight for Profitability? Read This Trend Analysis report
NII Holdings Inc (NASDAQ:NIHD) percentage change mounted 24.21% to close at $2.98 with the total traded volume of 27.82 million shares, and average volume of 7.10 million. The Company’s year to date performance remained optimistic with the rise of 8.4%. During last trade its minimum price was $2.65 and it gained its highest price of $3.05. NII Holdings, Inc., through its subsidiaries, provides wireless communication services under the Nextel brand name to businesses and individuals in Mexico, Brazil, Argentina, Peru, and Chile.
Will NIHD Continue To Move Higher? Find Out Here
Idenix Pharmaceuticals Inc (NASDAQ:IDIX) started its trading session with the price of $6.82 and closed at $8.01 by scoring 17.11%. The stocks traded with total volume of 3.99 million shares, while the average trading volume remained 1.28 million shares. Previous 5 days graph demonstrated a positive move of 22.48%. The 52-week price range of the stock remained $2.93 - $8.45. Idenix Pharmaceuticals, Inc., a biopharmaceutical company, together with its subsidiaries, engages in the discovery and development of drugs for the treatment of human viral diseases in the United States and France.
Why Should Investors Buy IDIX After The Recent Gain? Just Go Here and Find Out
Pacific Biosciences of California (NASDAQ:PACB) during the previous trading session, the stock showed a positive movement of 14.44%. PACB traded with volume of 2.70 million shares, while its average trading volume remained 774,635.00 shares. Stock’s closing price was $6.50 while it started its day-trade at $5.67. Its 52-week price range was $1.95 - $6.97. Pacific Biosciences of California, Inc. develops, manufactures, and markets an integrated platform for genetic analysis.
Will PACB Continue To Move Higher? Find Out Here
About King Penny Stocks
King Penny Stocks provides up to the minute dissemination of news while reporting on stocks that are actively traded in the small cap arena whether trading on the Nasdaq small caps, AMEX or the OTC markets. Since performance is key in our industry, it’s no wonder why our ground breaking alerts on active stocks have brought us to the forefront of this industry. Our due diligence on trend analysis has caught the attention of the very best chart technicians in the business.
King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Get detailed breakdowns of major trends impacting the markets?
Our newsletter, Press Release and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.
An individual should never invest in the securities of any of the company’s profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research. This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation.
Read our Full Disclaimer at: http://kingpennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)